Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers.
|CAT||Product Name||Target Species||TCR Clone||Host Species||Epitope||HLA||Vector Type||Inquiry & Datasheet|
|TCR-C014Z||Human anti-Bob1 T cell receptor (4G11), pCDTCR1||Human||4G11||Human||APAPTAVVL||HLA-B*0702||Lentiviral|
|TCR-C015Z||Human anti-Bob1 T cell receptor (3C10), pCDTCR1||Human||3C10||Human||YALNHTLSV||HLA-A*0201||Lentiviral|
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE